Login / Signup

Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb®) in the management of septic shock: A retrospective observational study.

Yogendra P SinghS C ChhabraK LashkariA TanejaA GargA ChandraM ChhabraG P SinghS Jain
Published in: The International journal of artificial organs (2019)
Hemoadsorption using the extracorporeal adsorption device (CytoSorb®) might be an effective rescue therapy in stabilizing septic shock patients.
Keyphrases
  • septic shock
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • aqueous solution
  • stem cells